Listing 3 - Actual negotiations

Indication:

Severe eosinophilic asthma, add-on maintenance treatment of in children (aged 6 years and older)

Indication:

Severe chronic rhinosinusitis with nasal polyps

Indication:

Multiple myeloma (MM) in adult patients who have received at least three prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 antibody, and who are refractory to their last treatment.

Indication:

Ulcerative Colitis

Indication:

Mycosis Fungoides (MF), S�zary Syndrome (SS)

Indication:

Unresectable hepatocellular carcinoma (uHCC) in adult patients who require systemic therapy, first-line treatment

Indication:

Locally advanced or metastatic biliary tract cancer (BTC) in combination with gemcitabine-based chemotherapy

Indication:

Generalized Myasthenia Gravis, AChR antibody-positive

Indication:

Multiple Indications

Indication:

Breast cancer, monotherapy for the treatment of adult patients, unresectable or metastatic HER2-low (IHC 1+ or IHC 2+/ISH-)